Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

OnabotulinumtoxinA for Chronic Headaches: Is 155 Units Superior to 100 Units?

NCT04349176 is registered in ClinicalTrials.gov with United States Naval Medical Center, San Diego as lead sponsor.

NCT NCT04349176
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04349176 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
OnabotulinumtoxinA for Chronic Headaches: Is 155 Units Superior to 100 Units?
Lead sponsor
United States Naval Medical Center, San Diego
Phase
Phase 3
Overall status
Terminated
Start date
May 12, 2017
Completion date
December 31, 2022
Enrollment
35 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic migraine, headache